GlassScriptPhysician profile
Demetrios Doukas
NPI 1801161906
$31,042.43
in general payments reported to CMS, 2019-2025
19 companies · $6,204 in 2025
The $6,204 reported for 2025 was more than what 85% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $861 · 2020: $15K · 2021: $998 · 2022: $5,458 · 2023: $1,653 · 2024: $710 · 2025: $6,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,083 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,000 · Travel and Lodging: $1,482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,083.45 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,000.00 |
| Travel and Lodging | $1,482.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $15,249.89 | 2019-2020 | |
| Abbott Laboratories | $7,898.07 | 2019-2025 | Amplatzer Amulet, Mitraclip, Ensite Precision |
| Medtronic, INC. | $4,870.72 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Biotronik INC. | $1,149.22 | 2020-2023 | Orsiro Mission |
| Cardiovascular Systems INC. | $370.57 | 2020-2023 | Diamondback Coronary |
| Janssen Pharmaceuticals, INC | $270.12 | 2019 | |
| Boston Scientific Corporation | $254.85 | 2022-2025 | Watchman Access System |
| Shockwave Medical, INC | $219.87 | 2025 | |
| Abiomed | $159.76 | 2023-2025 | Impella |
| Edwards Lifesciences Corporation | $153.13 | 2023-2024 | Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals LP | $124.55 | 2019 | |
| Tempus Ai, INC | $121.57 | 2025 | Egg-Af |
| Actelion Pharmaceuticals US, INC. | $55.63 | 2024 | Uptravi |
| Surmodics, INC. | $38.07 | 2022-2023 | Pounce Thrombectomy |
| Novartis Pharmaceuticals Corporation | $31.13 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $22.70 | 2023 | Cardiohelp |
| Cook Medical LLC | $19.80 | 2021 | |
| Amgen INC. | $19.70 | 2024 | Repatha |
| W. L. Gore & Associates, INC. | $13.08 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Demetrios Doukas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.